Related references
Note: Only part of the references are listed.Cerebrospinal fluid A42 levels and APP processing pathway genes in Parkinson's disease
Lynn M. Bekris et al.
MOVEMENT DISORDERS (2015)
Biomarkers of cognitive decline in Parkinson's disease
Chin-Hsien Lin et al.
PARKINSONISM & RELATED DISORDERS (2015)
CSF Aβ42 predicts early-onset dementia in Parkinson disease
Guido Alves et al.
NEUROLOGY (2014)
Cerebrospinal fluid amyloid-β and phenotypic heterogeneity in de novo Parkinson's disease
Guido Alves et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Cerebrospinal fluid A levels correlate with structural brain changes in Parkinson's disease
Mona K. Beyer et al.
MOVEMENT DISORDERS (2013)
Alzheimer's disease and Parkinson's disease genome-wide association study top hits and risk of Parkinson's disease in Korean population
Sun Ju Chung et al.
NEUROBIOLOGY OF AGING (2013)
Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia
Stephen N. Gomperts et al.
NEUROLOGY (2013)
TREM2 and Neurodegenerative Disease
Christiane Reitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Analysis of Genome-Wide Association Studies of Alzheimer Disease and of Parkinson Disease to Determine If These 2 Diseases Share a Common Genetic Risk
Valentina Moskvina et al.
JAMA NEUROLOGY (2013)
Association of Cerebrospinal Fluid β-Amyloid 1-42, T-tau, P-tau181, and α-Synuclein Levels With Clinical Features of Drug-Naive Patients With Early Parkinson Disease
Ju-Hee Kang et al.
JAMA NEUROLOGY (2013)
An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer's and Lewy body pathology
Christian Wider et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment
Per Svenningsson et al.
LANCET NEUROLOGY (2012)
Association of a protective paraoxonase 1 (PON1) polymorphism in Parkinson's disease
Andrea Carmine Belin et al.
NEUROSCIENCE LETTERS (2012)
A Common BACE1 Polymorphism Is a Risk Factor for Sporadic Creutzfeldt-Jakob Disease
Olga Calero et al.
PLOS ONE (2012)
Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's disease
L. M. Bekris et al.
NEUROBIOLOGY OF AGING (2011)
Apolipoprotein E genotypes and the risk of Parkinson disease
Jianjun Gao et al.
NEUROBIOLOGY OF AGING (2011)
Association of variants within APOE, SORL1, RUNX1, BACE1 and ALDH18A1 with dementia in Alzheimer's disease in subjects with Down syndrome
Ashok Patel et al.
NEUROSCIENCE LETTERS (2011)
Replication of CLU, CR1, and PICALM Associations With Alzheimer Disease
Minerva M. Carrasquillo et al.
ARCHIVES OF NEUROLOGY (2010)
Association of the MAPT locus with Parkinson's disease
C. Wider et al.
EUROPEAN JOURNAL OF NEUROLOGY (2010)
Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate α-secretase activity
Minji Kim et al.
HUMAN MOLECULAR GENETICS (2009)
Incidence of Parkinson's disease in Norway: the Norwegian ParkWest study
G. Alves et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease
Eric M. Reiman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The progression of pathology in longitudinally followed patients with Parkinson's disease
Glenda Halliday et al.
ACTA NEUROPATHOLOGICA (2008)
Association of BACE1 gene polymorphism with Alzheimer's disease in Asian populations: Meta-analysis including Korean samples
Sangmee A. Jo et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2008)
Parkinson's disease: clinical features and diagnosis
J. Jankovic
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Promoter polymorphisms which modulate APP expression may increase susceptibility to Alzheimer's disease
Haiyan Lv et al.
NEUROBIOLOGY OF AGING (2008)
Polymorphisms at the paraoxonase 1 L55M and Q192R loci affect the pathophysiology of Alzheimer's disease: Emphasis on the cholinergic system and beta-amyloid levels
Valerie Leduc et al.
NEURODEGENERATIVE DISEASES (2008)
ApoE promotes the proteolytic degradation of Aβ
Qingguang Jiang et al.
NEURON (2008)
Clinical diagnostic criteria for dementia associated with Parkinson's disease
Murat Emre et al.
MOVEMENT DISORDERS (2007)
SNPStats:: a web tool for the analysis of association studies
Xavier Sole et al.
BIOINFORMATICS (2006)
Chromosome 21 BACE2 haplotype associates with Alzheimer's disease:: A two-stage study
L Myllykangas et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
Genetic studies of A2M and BACEI genes in Chinese Han Alzheimer's disease patients
L Cai et al.
NEUROREPORT (2005)
Association study between Alzheimer's disease and genes involved in Aβ biosynthesis, aggregation and degradation:: suggestive results with BACE1
J Clarimón et al.
JOURNAL OF NEUROLOGY (2003)
Polymorphism in the BACE gene influences the risk for Alzheimer's disease
CM Kirschling et al.
NEUROREPORT (2003)
Association studies using novel polymorphisms in BACE1 and BACE2
P Nowotny et al.
NEUROREPORT (2001)